Core Viewpoint - Sana Biotechnology, Inc. is set to present at four investor conferences in September 2025, providing a business overview and updates on its engineered cell therapies [1][5]. Company Overview - Sana Biotechnology focuses on creating engineered cells as medicines, aiming to repair and control genes, and replace missing or damaged cells [3]. - The company operates in Seattle, WA, Cambridge, MA, and South San Francisco, CA [3]. Upcoming Events - Sana will present at the following conferences: - Citi's 2025 Biopharma Back-to-School Conference on September 2, 2025, at 3:15 p.m. ET [5]. - 2025 Wells Fargo Healthcare Conference on September 4, 2025, at 8:00 a.m. ET [5]. - Morgan Stanley 23 Annual Global Healthcare Conference on September 8, 2025, at 11:30 a.m. ET [5]. - HC Wainwright 27 Annual Global Investment Conference on September 9, 2025, at 9:30 a.m. ET [5]. Investor Relations - Webcasts of the presentations will be available on the Investor Relations page of Sana's website, with replays accessible for 30 days post-conference [2].

Group 1 - Sana Biotechnology, Inc. has successfully closed the sale of 3,358,208 shares of its common stock at a price of $3.35 per share, resulting in total gross proceeds of approximately $86.3 million [1] - The offering was part of a previously announced underwritten public offering that closed on August 8, 2025, and included the full exercise of the underwriters' option to purchase additional shares [1] - The joint book-running managers for the offering included Morgan Stanley, Goldman Sachs & Co. LLC, BofA Securities, and TD Cowen [2] Group 2 - The offering was conducted under a Registration Statement on Form S-3, which was previously filed and declared effective by the SEC [3] - Final prospectus supplement and accompanying prospectus related to the offering have been filed with the SEC and are accessible through the SEC's website [3] - Sana Biotechnology is focused on creating and delivering engineered cells as medicines for patients, with operations in Seattle, WA, Cambridge, MA, and South San Francisco, CA [5]